Can Circulating CD34+ Cell Count Be Used for the Prognosis of Myelofibrosis?
BRITISH JOURNAL OF HAEMATOLOGY（2023）
Key words
CD34,myelofibrosis,ruxolitinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined